SECTIONS
SUBSCRIBE
Managed Care

Search form

  • News
  • Politics & policy
  • Drug management
  • Payers
  • Providers
  • Current Issue
  • More
    • Past issues
    • Value-Based Care
    • Profiles
    • Conversations
    • Tomorrow's Medicine
    • Original research
    • Pharm D Corner
    • Viewpoints
    • Legislation & regulation
    • Contact Us

Most Popular

FDA Authorizes New Use of Test, First to Identify the Emerging Pathogen Candida Auris

The FDA has authorized the first test to identify the emerging pathogen Candida auris, which can cause serious infections in hospitalized patients. Specifically, the FDA permitted marketing for a new use of the BRUKER MALDI Biotyper CA system (Bruker Daltonik GmbH) for the identification of C. auris,…
Read more

Tavalisse Approved for Treatment of Chronic Immune Thrombocytopenia

The FDA has approved fostamatinib disodium hexahydrate (Tavalisse, Rigel Pharmaceuticals, Inc.) for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Fostamatinib is an oral spleen tyrosine kinase…
Read more

Amazon, Apple on health care hiring kicks

Many think that a marriage between the tech and health sectors would be a match made in heaven, but so far here on plain old planet Earth, it’s been at most a flirtation.  But big tech is doing some health care hiring, so perhaps something real is starting to happen.  Stat reported recently…
Read more

Pages

  • « first
  • ‹ previous
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
Facebook Twitter LinkedIn RSS Feed
  • Contact Us
  • Our History
  • Terms & Conditions of Use Agreement
  • Address and Subscription Changes
  • 2018 Editorial Calendar
  • 2018 Space and Material Due Dates
  • BPA Statement
  • Submitting Original Research
  • Submitting Viewpoints
  • Site Map
  • Contact Webmaster
  • P&T Community
© 2018 MediMedia, an ICON plc company. All rights reserved.